 |
Lead Discovery |  |
Lead Optimization | |
Preclinical Development |  |
Clinical Development |  |
 |
Pharmacopeia has assembled expertise in clinical development through its employees, Clinical Advisory Board and consultants worldwide to help design, set-up and manage its clinical trials. We are actively building relationships today with key academic groups and clinical research institutions with the capability to support our clinical trials.
Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical needs. The company has a broad portfolio of clinical and preclinical candidates under development internally or with partners including seven clinical compounds in Phase 2 or Phase 1 development addressing hypertension, diabetic nephropathy, muscle wasting, inflammation and respiratory disease. The company is leveraging its fully integrated drug discovery platform to sustain the growth of its development pipeline. Pharmacopeia has established strategic alliances with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Cephalon, GlaxoSmithKline, Schering-Plough, and Wyeth Pharmaceuticals.
For more information on some of the conditions our drugs will treat, please follow the links below:
